Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02553564 · ClinicalTrials.gov registry record · NA
30 Day Rehospitalization Risk in Hemodialysis Patients
A NA study, sponsored by Northwell Health.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02553564: Clinical Trial NA study, sponsored by Northwell Health.
NCT02553564 is a NA study that was terminated before completion, run by Northwell Health. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02553564, a NA study, was terminated before completion, sponsored by Northwell Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
After a hospitalization, dialysis patients have a high risk of being admitted to the hospital again within 30 days. The purpose of this research study is to test a new way of reducing the chance of patients being hospitalized again. In this study investigator will evaluate a checklist driven evaluation upon return to the dialysis facility as a method to reduce the rate of rehospitalizations in hemodialysis patients.
Primary Outcome
Percentage of patients in each group requiring readmission to an acute care hospital within 30 days of discharge after an acute care hospitalization.
Interventions
- OTHER Checklist driven clinical encounter after hospital discharge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-11-22 |
| Est. Completion | 2018-03-15 |
| Phase | NA |
Why NCT02553564 stopped before completion
NCT02553564 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Checklist driven clinical encounter after hospital discharge is the first listed.
NCT02553564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02553564 about?
NCT02553564 is a clinical study titled "30 Day Rehospitalization Risk in Hemodialysis Patients". After a hospitalization, dialysis patients have a high risk of being admitted to the hospital again within 30 days. The purpose of this research study is to test a new way of reducing the chance of patients being hospitalized again. In this study investigator will evaluate a checklist driven evaluat...
What is the current status of trial NCT02553564?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-11-22. Estimated completion is 2018-03-15.
What interventions are being tested in trial NCT02553564?
The interventions under investigation include: Checklist driven clinical encounter after hospital discharge (OTHER).
Who is sponsoring clinical trial NCT02553564?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02553564's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI